101. Introduction of hypothermia for neonates with perinatal asphyxia in the Netherlands and Flanders
- Author
-
Groenendaal, F., Casaer, A., Dijkman, K.P., Gavilanes, A.W.D., Haan, T.R. de, Horst, H.J. ter, Laroche, S., Naulaers, G., Rijken, M., Straaten, H.L.M. van, Steiner, K., Swarte, R.M.C., Zecic, A., Zonnenberg, I.A., Dutch-Flemish Working Grp Neonatal, Pediatric surgery, ICaR - Circulation and metabolism, Pediatrics, Faculteit Medische Wetenschappen/UMCG, Dutch-Flemish Working Grp Neonatal, Kindergeneeskunde, RS: MHeNs School for Mental Health and Neuroscience, ANS - Amsterdam Neuroscience, Other Research, and Neonatology
- Subjects
Male ,Pediatrics ,medicine.medical_specialty ,THERAPEUTIC HYPOTHERMIA ,BIRTH ,Developmental Disabilities ,WHOLE-BODY HYPOTHERMIA ,Treatment outcome ,Neurodevelopment ,INFANTS ,Gestational Age ,Hypothermia ,CONTROLLED-TRIAL ,TERM ,Congenital Abnormalities ,Belgium ,Hypothermia, Induced ,Intensive care ,otorhinolaryngologic diseases ,medicine ,Birth Weight ,Humans ,HYPOXIC-ISCHEMIC ENCEPHALOPATHY ,Hearing Loss ,Netherlands ,RISK ,Asphyxia Neonatorum ,Introduction ,business.industry ,Cerebral Palsy ,Infant, Newborn ,Functional imaging [IGMD 1] ,medicine.disease ,Neuroprotection ,SUBCUTANEOUS FAT NECROSIS ,Perinatal asphyxia ,Treatment Outcome ,Pediatrics, Perinatology and Child Health ,Intensive Care, Neonatal ,Female ,Human medicine ,SYSTEMIC HYPOTHERMIA ,medicine.symptom ,business ,Developmental Biology - Abstract
Background: Therapeutic hypothermia was introduced in the Netherlands and Flanders, Belgium, in 2008. Since then, an increasing number of patients has been treated - up to 166 in 2010. Complications and outcome were registered in an online database. Objectives: The aim of this study was to analyse complications and outcome after implementation. Methods: Data were retrieved from an online database to which all centres had contributed. Results: In 3 years, 332 patients were treated. Excluding 24 patients with congenital abnormalities or metabolic disorders, mortality was 31.8%. Of the 210 survivors without congenital malformations, 21 had cerebral palsy, another 19 a developmental delay of more than 3 months at the age of at least 24 months, and 2 had severe hearing loss. The total adverse outcome, combining death and adverse neurodevelopment, in 308 patients without congenital malformations is 45.5%, which is similar to that of the large trials. Conclusions: The introduction of therapeutic hypothermia for neonates with perinatal asphyxia in the Netherlands and Flanders has been rapid and successful, with results similar to findings in the randomised controlled trials.
- Published
- 2013
- Full Text
- View/download PDF